AusPAR: Crizanlizumab

Australian Public Assessment Report

AusPAR

AusPAR: Crizanlizumab [PDF, 887.49 KB]

AusPAR: Crizanlizumab [Word, 1.08 MB]

Attachment 1: Product Information for Crizanlizumab [PDF, 236.95 KB]

Attachment 1: Product Information for Crizanlizumab [Word, 59.2 KB]

Device/Product Name

Adakveo

Active ingredients

Crizanlizumab

AusPAR Date

16 July 2021

Published

24 August 2021

Submission Number

PM-2019-05705-1-6

Submission Type

New biological entity

Decision

Approved